All In MedTech

Device Trial Radar · NCT05820087

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

The HistoSonics Edison System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY US)

Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

67

Actual

Start

Jan 4, 2024

Primary completion

Sep 4, 2025

Study completion Jul 2030

Sponsor

Lead sponsor
HistoSonics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 19, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to evaluate the effectiveness and safety of the HistoSonics Edison System for the destruction of kidney tissue by treating primary solid renal tumors.

Conditions

  • Renal Cancer
  • Tumor, Solid
  • Kidney Cancer
  • Tumor
  • Tumor, Benign

Interventions

  • HistoSonics Edison SystemDevice

    Non-invasive destruction of kidney tissue using histotripsy, a non-thermal mechanical process of focused ultrasound.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Effectiveness Endpoint - Primary technique efficacy defined as the percentage of targeted tumors that were successfully eliminated after a single histotripsy session as assessed by contrast enhanced MRI or CT at 90 days.Time frame: 90 days Post Index Procedure
  2. Primary Safety Endpoint - Freedom from index procedure related major complications, defined by Clavien-Dindo Classification Grade 3 or higher up to 30 days after the histotripsy procedure.Time frame: 30 days Post Index Procedure

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • University of Southern California

    Los Angeles, California

  • University of California, Los Angeles (UCLA)

    Los Angeles, California

  • Providence Mission Hosptial

    Mission Viejo, California

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.